Citation: Jp. Vandenbroucke, MAINTAINING PRIVACY AND THE HEALTH OF THE PUBLIC - SHOULD NOT BE SEENAS IN OPPOSITION, BMJ. British medical journal, 316(7141), 1998, pp. 1331-1332
Citation: Sftm. Debruijn et al., CASE-CONTROL STUDY OF RISK OF CEREBRAL SINUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF HEREDITARY PROTHROMBOTIC CONDITIONS, BMJ. British medical journal, 316(7131), 1998, pp. 589-592
Citation: Jp. Vandenbroucke, BIAS IN METAANALYSIS DETECTED BY A SIMPLE, GRAPHICAL TEST - EXPERTS VIEWS ARE STILL NEEDED, BMJ. British medical journal, 316(7129), 1998, pp. 469-470
Citation: Jp. Vandenbroucke, OBSERVATIONAL RESEARCH AND EVIDENCE-BASED MEDICINE - WHAT SHOULD WE TEACH YOUNG PHYSICIANS, Journal of clinical epidemiology, 51(6), 1998, pp. 467-472
Authors:
BLOEMENKAMP KWM
ROSENDAAL FR
HELMERHORST FM
KOSTER T
BERTINA RM
VANDENBROUCKE JP
Citation: Kwm. Bloemenkamp et al., HEMOSTATIC EFFECTS OF ORAL-CONTRACEPTIVES IN WOMEN WHO DEVELOPED DEEP-VEIN THROMBOSIS WHILE USING ORAL-CONTRACEPTIVES, Thrombosis and haemostasis, 80(3), 1998, pp. 382-387
Citation: Cjm. Doggen et al., A GENETIC PROPENSITY TO HIGH FACTOR-VII IS NOT ASSOCIATED WITH THE RISK OF MYOCARDIAL-INFARCTION IN MEN, Thrombosis and haemostasis, 80(2), 1998, pp. 281-285
Authors:
SIMON CH
VLIELAND TPMV
DIJKMANS BAC
MOENS HJB
JANSSEN M
HAZES JMW
FRANKEN HCM
VANDENBROUCKE JP
BREEDVELD FC
Citation: Ch. Simon et al., LABORATORY SCREENING FOR SIDE-EFFECTS OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN DAILY RHEUMATOLOGICAL PRACTICE, Scandinavian journal of rheumatology, 27(3), 1998, pp. 170-179
Authors:
HELMERHORST FM
ROSENDAAL FR
VANDENBROUCKE JP
Citation: Fm. Helmerhorst et al., THE PILL AND VENOUS THROMBOEMBOLISM - A DISARRAY OF SEVERAL LAYERS OFDEBATE, Human reproduction, 13(5), 1998, pp. 1119-1120
Authors:
HELMERHORST FM
ROSENDAAL FR
VANDENBROUCKE JP
Citation: Fm. Helmerhorst et al., VENOUS THROMBOEMBOLISM AND THE PILL - THE WHO TECHNICAL REPORT ON CARDIOVASCULAR-DISEASE AND STEROID-HORMONE CONTRACEPTION - STATE-OF-THE-ART, Human reproduction (Oxford. Print), 13(11), 1998, pp. 2981-2983
Citation: Sftm. Debruijn et al., INCREASED RISK OF CEREBRAL VENOUS SINUS THROMBOSIS WITH 3RD-GENERATION ORAL-CONTRACEPTIVES, Lancet, 351(9113), 1998, pp. 1404-1404
Authors:
HILLE ETM
VANDUIJN E
GRUIS NA
ROSENDAAL FR
BERGMAN W
VANDENBROUCKE JP
Citation: Etm. Hille et al., EXCESS CANCER MORTALITY IN 6 DUTCH PEDIGREES WITH THE FAMILIAL ATYPICAL MULTIPLE MOLE-MELANOMA SYNDROME FROM 1830 TO 1994, Journal of investigative dermatology, 110(5), 1998, pp. 788-792
Authors:
OOSTERKAMP HM
BRAND A
KLUINNELEMANS JC
VANDENBROUCKE JP
Citation: Hm. Oosterkamp et al., PREGNANCY AND SEVERE APLASTIC-ANEMIA - CAUSAL RELATION OR COINCIDENCE, British Journal of Haematology, 103(2), 1998, pp. 315-316
Authors:
SIMON CH
DIJKMANS BAC
MOENS HJB
VANDENBROUCKE JP
BREEDVELD FC
VLIELAND TPMV
Citation: Ch. Simon et al., INCIDENCE AND SEVERITY OF LABORATORY ABNORMALITIES DURING TREATMENT WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN PATIENTS WITH RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 41(9), 1998, pp. 1073-1073
Authors:
VANDENBORNE BEEM
LANDEWE RBM
HOUKES I
SCHILD F
VANDERHEYDEN PCW
HAZES JMW
VANDENBROUCKE JP
ZWINDERMAN AH
THE HSG
BREEDVELD FC
MOENS HJB
KLUIN PM
DIJKMANS BAC
Citation: Beem. Vandenborne et al., NO INCREASED RISK OF MALIGNANCIES AND MORTALITY IN CYCLOSPORINE A-TREATED PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(11), 1998, pp. 1930-1937
Authors:
VANDENBROUCKE JP
HELMERHORST FM
ROSENDAAL FR
Citation: Jp. Vandenbroucke et al., EPIDEMIOLOGY OF ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE, Annals of internal medicine, 129(9), 1998, pp. 747-747
Authors:
VANDENBROUCKE JP
ROSENDAAL FR
HELMERHORST FM
Citation: Jp. Vandenbroucke et al., SCIENTIFIC PROBLEMS WITH A NONCAUSAL ARTIFACT - REPLY, American journal of obstetrics and gynecology, 178(5), 1998, pp. 1106-1107
Citation: Jp. Vandenbroucke, SHOULD ORAL-CONTRACEPTIVE USERS BE SCREENED FOR FACTOR-V-LEIDEN - ORAL-CONTRACEPTIVES ARE NOT THE ONLY EFFECTIVE CONTRACEPTIVES - REPLY, BMJ. British medical journal, 315(7099), 1997, pp. 60-60
Authors:
DOGGEN CJM
VISSER T
CATS VM
BERTINA RM
REITSMA PH
VANDENBROUCKE JP
ROSENDAAL FR
Citation: Cjm. Doggen et al., A COMMON VARIANT OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS NOT A RISK FACTOR FOR MYOCARDIAL-INFARCTION IN MEN, Thrombosis and haemostasis, 1997, pp. 395-395
Authors:
TANIS BC
ROSENDAAL FR
KOSTER T
VANDENBROUCKE JP
Citation: Bc. Tanis et al., COMBINED EFFECT OF IMMOBILIZATION AND HEMOSTATIC RISK-FACTORS ON DEEPVENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 732-732
Authors:
BLOEMENKAMP KWM
ROSENDAAL FR
HELMERHORST FM
KOSTER T
BERTINA RM
VANDENBROUCKE JP
Citation: Kwm. Bloemenkamp et al., HEMOSTATIC EFFECTS OF ORAL-CONTRACEPTIVES IN WOMEN WHO HAD PREVIOUSLYDEVELOPED DEEP-VEIN THROMBOSIS WHILE USING ORAL-CONTRACEPTIVES, Thrombosis and haemostasis, 1997, pp. 786-786